Showing 1 - 10 of 60
Persistent link: https://www.econbiz.de/10004999468
Persistent link: https://www.econbiz.de/10005602880
Persistent link: https://www.econbiz.de/10005376122
Persistent link: https://www.econbiz.de/10005376152
The goal of this paper is to present an optimal resource allocation model for the regional allocation of public service inputs. The proposed solution leads to maximise the relative public service availability in regions located below the best availability frontier, subject to exogenous budget...
Persistent link: https://www.econbiz.de/10005827425
Informal care is today the form of support most commonly used by those who need other people in order to carry out certain activities that are considered basic (eating, dressing, taking a shower, etc.), in Spain and in most other countries in the region. The possible labour opportunity costs...
Persistent link: https://www.econbiz.de/10005827426
Despite the importance of supplier inducement and brand loyalty in the drug purchasing process, little empirical evidence is to be found with regard to the influence that these factors exert on patients’ decisions. Under the new scenario of easier access to information, patients are becoming...
Persistent link: https://www.econbiz.de/10005827427
This paper studies oligopolistic competition in off-patent pharmaceutical markets using a vertical product differentiation model. This model can explain the observation that countries with stronger regulations have smaller generic market shares. It can also explain the differences in observed...
Persistent link: https://www.econbiz.de/10005827428
This paper presents a method for the measurement of changes in health inequality and income-related health inequality over time in a population. For pure health inequality (as measured by the Gini coefficient) and income-related health inequality (as measured by the concentration index), we show...
Persistent link: https://www.econbiz.de/10005827429
The trade-off between property rights/price regulation and innovation depends on country characteristics and drug industry specificities. Access to drugs and innovation can be reconciled by seven ways that, among others, include: public health strengthening in the countries with the largest...
Persistent link: https://www.econbiz.de/10005827430